The AHA Dec. 17 urged Elevance Health, which is the parent company of the Anthem brand of health plans, to rescind Anthem’s nonparticipating provider policy that is set to go into effect Jan. 1, ...

The House yesterday passed the Lower Health Care Premiums for All Americans Act (H.R. 6703), legislation to expand association health plans, increase transparency requirements for pharmacy benefit ...

The Department of Health and Human Services today announced three regulatory actions related to the practice of “sex-rejecting procedures” on children.

The Centers for Medicare & Medicaid Services announced today that it will launch a voluntary payment model designed to broadly reach more health care providers who have not joined accountable care ...

The AHA has released its 2026 Environmental Scan, a comprehensive resource designed to help hospitals and health systems navigate a rapidly evolving landscape. The scan provides data and trends that ...

The American Organization for Nursing Leadership today announced Robyn Begley as the 2026 recipient of its Lifetime Achievement Award. The award recognizes leaders in nursing who have served the ...

America’s hospitals, health systems and its caregivers have significant concerns regarding Anthem’s nonparticipating provider policy1 and the harm it will inflict on patients.

At NYC Health + Hospitals/Lincoln, a new hotspotting program launched in April uses predictive analytics and intensive follow ...

The health care sector reached a major milestone this month with the opening of the nation’s first all-electric acute care ...

The Centers for Medicare & Medicaid Services released a memo Dec. 16 announcing the agency’s intent to conduct a voluntary pilot in 2026, called the Service Level Data Collection for Initial ...

In this special Leadership Dialogue conversation, Tina Freese Decker, president and CEO of Corewell Health and outgoing AHA board chair, sits down with Marc Boom, M.D., president and CEO of Houston ...

An AHA blog examines new data released by the Health Resources and Services Administration on the growth of the 340B Drug ...